A pilot feasibility study of non-myeloablative allogeneic hematopoietic stem cell transplantation for refractory Crohn Disease
- 28 May 2020
- journal article
- letter
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 55 (12) , 2343-2346
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Autologous Haematopoietic Stem Cell Transplantation (AHSCT) in Severe Crohn’s Disease: A Review on Behalf of ECCO and EBMTJournal of Crohn's and Colitis, 2018
- Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn’s diseaseBMC Research Notes, 2017
- Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trialThe Lancet Gastroenterology & Hepatology, 2017
- Autologous Haematopoietic Stem Cell Transplantation for Refractory Crohn’s Disease: Efficacy in a Single-Centre CohortJournal of Crohn's and Colitis, 2017
- Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn DiseaseJAMA, 2015
- Remission of refractory Crohn's disease by high‐dose cyclophosphamide and autologous peripheral blood stem cell transplantationAlimentary Pharmacology & Therapeutics, 2012
- Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's diseaseJournal of Crohn's and Colitis, 2011
- Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-upBlood, 2010
- Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn’s diseaseGut, 2007
- Complete Clinical Remission after High-Dose Immune Suppression and Autologous Hematopoietic Stem Cell Transplantation in Severe Crohn’s Disease Refractory to Immunosuppressive and Immunomodulator TherapyInflammatory Bowel Diseases, 2004